Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terguride for fibromyalgia pain: randomized double-blind placebo-controlled phase 2 trial
2006-002477-45Phase 2Completed
- Sponsor
- ErgoNex Pharma
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Terguride with Placebo (2 arms). Primary endpoint: Change in fibromyalgia-associated pain intensity on VAS. Started Nov 2006; status: completed.
02
Drugs
terguride
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-002477-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002477-45.